Autophagy of Spinal Microglia Affects the Activation of Microglia through the PI3K/AKT/mTOR Signaling Pathway

Jingjuan Li1, Xin Cheng2, Dan Fu3

  • 1Department of Anesthesiology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510900, China.

Neuroscience
|December 13, 2021
PubMed

Insights

Mild hypothermia improves ischemic spinal cord injury (ISCI) by enhancing autophagy and reducing microglia activation. This mechanism, involving PI3K/AKT/mTOR pathway inhibition, offers a potential therapeutic strategy for ISCI patients.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Surgical Research

Background:

  • Ischemic spinal cord injury (ISCI) can cause delayed paralysis after aortic aneurysm repair.
  • Mild hypothermia shows promise in improving ISCI outcomes, but its underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the protective mechanisms of mild hypothermia against ISCI in a rat model.
  • To explore the role of microglia activation and autophagy in ISCI and the effects of hypothermia.

Main Methods:

  • Induced ISCI in rats via aortic cross-clamping and treated with mild hypothermia.
  • Utilized an oxygen-glucose deprivation (OGD) model in BV-2 mouse microglia cells, treated with rapamycin.
  • Analyzed microglia activation, autophagy levels, and the PI3K/AKT/mTOR pathway in both models.

Main Results:

  • Mild hypothermia partially improved ISCI in rats, significantly inducing autophagy and reversing excessive microglia activation.
  • In vitro, OGD induced microglia activation and moderate autophagy; rapamycin enhanced autophagy and reversed microglia activation.
  • The PI3K/AKT/mTOR pathway was inhibited in both ISCI and OGD models, with further inhibition by hypothermia or rapamycin.

Conclusions:

  • Enhanced autophagy, potentially via PI3K/AKT/mTOR pathway inhibition, is a key mechanism by which mild hypothermia protects against ISCI.
  • Targeting autophagy presents a promising therapeutic avenue for mitigating ISCI.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.8K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K